Evaluation of the early-phase [18F]AV45 PET as an optimal surrogate of [18F]FDG PET in ageing and Alzheimer’s clinical syndrome
Open Access
- 1 January 2021
- journal article
- research article
- Published by Elsevier in NeuroImage: Clinical
- Vol. 31, 102750
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Hippocampal subfield volumetry in mild cognitive impairment, Alzheimer's disease and semantic dementiaNeuroImage: Clinical, 2013
- Correlation of Amyloid PET Ligand Florbetapir F 18 Binding With Aβ Aggregation and Neuritic Plaque Deposition in Postmortem Brain TissueAlzheimer Disease & Associated Disorders, 2012
- Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCINeurobiology of Aging, 2011
- In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18)Journal of Nuclear Medicine, 2010
- Cerebral Blood Flow Response to Functional ActivationJournal of Cerebral Blood Flow & Metabolism, 2009
- Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s diseaseEuropean Journal of Nuclear Medicine and Molecular Imaging, 2008
- Regional Differences in the Coupling between Resting Cerebral Blood Flow and Metabolism may Indicate Action Preparedness as a Default StateCerebral Cortex, 2008
- Mild Cognitive Impairment as a Clinical Entity and Treatment TargetArchives of Neurology, 2005
- Genuine memory deficits in dementiaDevelopmental Neuropsychology, 1987
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984